Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitors
Xuri Li, … , Ulf Eriksson, Peter Carmeliet
Xuri Li, … , Ulf Eriksson, Peter Carmeliet
Published January 3, 2005
Citation Information: J Clin Invest. 2005;115(1):118-127. https://doi.org/10.1172/JCI19189.
View: Text | PDF
Article Cardiology

Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitors

  • Text
  • PDF
Abstract

The angiogenic mechanism and therapeutic potential of PDGF-CC, a recently discovered member of the VEGF/PDGF superfamily, remain incompletely characterized. Here we report that PDGF-CC mobilized endothelial progenitor cells in ischemic conditions; induced differentiation of bone marrow cells into ECs; and stimulated migration of ECs. Furthermore, PDGF-CC induced the differentiation of bone marrow cells into smooth muscle cells and stimulated their growth during vessel sprouting. Moreover, delivery of PDGF-CC enhanced postischemic revascularization of the heart and limb. Modulating the activity of PDGF-CC may provide novel opportunities for treating ischemic diseases.

Authors

Xuri Li, Marc Tjwa, Lieve Moons, Pierre Fons, Agnes Noel, Annelii Ny, Jian Min Zhou, Johan Lennartsson, Hong Li, Aernout Luttun, Annica Pontén, Laetitia Devy, Ann Bouché, Hideyasu Oh, Ann Manderveld, Silvia Blacher, David Communi, Pierre Savi, Françoise Bono, Mieke Dewerchin, Jean-Michel Foidart, Monica Autiero, Jean-Marc Herbert, Désiré Collen, Carl-Henrik Heldin, Ulf Eriksson, Peter Carmeliet

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Therapeutic revascularization with PDGF-CC in ischemic heart. (A–C) Immu...
Therapeutic revascularization with PDGF-CC in ischemic heart. (A–C) Immunostaining, revealing low PDGF-Rα expression in a subset of microvessels in an uninjured myocardium (A) and strongly increased PDGF-Rα expression in sprouting vessels in the border region of a myocardial infarct, from where vessels revascularize the infarct (B and C). C shows a detail of PDGF-Rα expression in microvessels (arrows). (D) Upper and middle panels: immunoprecipitation and subsequent Western blotting for PDGF-Rα (upper) and pTyr (middle) showed that PDGF-Rα was upregulated in the ischemic myocardial regions bordering the infarct where vessels start to grow. Note also that PDGF-Rα was activated more in the borders than the normal (nonischemic) regions and maximally after PDGF-CC treatment. Lower panel: Coomassie staining revealing comparable loading. (E and F) PDGF-CC protein treatment increased TM+ (E) and SMA+ (F) vessel density in the infarcted areas in a dose-dependent manner. *P < 0.05 vs. vehicle. (G–I) TM immunostaining of myocardial vessels, revealing increased vessel densities after PDGF-CC treatment. (J–L) α-SMA immunostaining of myocardial vessels, revealing increased vessel densities after PDGF-CC treatment. Scale bars: 50 μm in A, B, G–L and 20 μm in C.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts